Skip to main content
. Author manuscript; available in PMC: 2012 Apr 23.
Published in final edited form as: J Rehabil Res Dev. 2010;47(1):61–66. doi: 10.1682/jrrd.2008.10.0144

Figure 3.

Figure 3

(A) Average percentage increase in survival area via TID treatment with and without NO donors.(B) Flap perfusion of the different nitric oxide treatments via TID treatment and control. SNP=sodium nitroprusside; DETA-NO= diethyltriamine NONOate. N=4 per group. Values are means ± SD.. † P<.05 vs. SHAM, * p<.05 vs. INJ Control, # P< .05 vs. SNP 1.25 mg (TID).